Detalhe da pesquisa
1.
Hyperbaric oxygen therapy for hypoxic-ischemic encephalopathy in non-fatal drowning.
Undersea Hyperb Med
; 48(1): 53-56, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648033
2.
Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre.
Eur Arch Otorhinolaryngol
; 276(7): 1881-1887, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31165255
3.
The effectiveness of hyperbaric oxygen therapy for managing radiation-induced proctitis - results of a 10-year retrospective cohort study.
Front Oncol
; 13: 1235237, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637048
4.
Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma - a narrative review.
Front Oncol
; 13: 1254322, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823059
5.
Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.
Front Neurol
; 13: 886603, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847231
6.
Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study.
Int J Radiat Oncol Biol Phys
; 114(3): 399-408, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35870712
7.
First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta.
Curr Oncol
; 28(3): 2270-2280, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34207443
8.
Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment.
BMJ Case Rep
; 14(5)2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031062
9.
Hyperbaric oxygen therapy as a complementary treatment for radiation proctitis: Useless or useful? - A literature review.
World J Gastroenterol
; 27(27): 4413-4428, 2021 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34366613
10.
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
Cancer Med
; 9(14): 4918-4928, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529797
11.
Nasopharyngeal carcinoma: our experience.
Eur Arch Otorhinolaryngol
; 266(6): 833-8, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18830701
12.
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease.
Ther Adv Med Oncol
; 10: 1758835918818346, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30619511